Search results

• Serotonin (redirect from Serotonin releasers) (category All articles with unsourced statements) (section Releasing agents)
  researched for the treatment of insomnia with limited success. A serotonin releasing agent is a drug that induces the release of serotonin from the presynaptic
  11 KB (1,321 words) - 19:33, 30 April 2024
• Releasing agent (category All articles with unsourced statements)
  methamphetamine is a potent releasing agent of dopamine and noradrenaline, but is a weak releaser of serotonin. A majority of releasing agents are non-selective
  4 KB (532 words) - 23:09, 21 April 2024
• MAOI (category All articles with unsourced statements) (section Psychoactive naturally occurring sources with high tyramine content)
  D2: CBD, Releasing agents and monoamine releasing agent (MRA) (or monoamine releaser) Dopamine releasing agent (DRA) Norepinephrine releasing agent (NRA)
  41 KB (4,274 words) - 07:47, 16 May 2024
• ΑMT (category All articles with unsourced statements)
  in excessive doses or when combined with MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of serotonin and
  25 KB (2,825 words) - 16:14, 28 November 2022
• MDA (category All articles with unsourced statements)
  MDMA (Ecstasy). As with MDMA, MDA is thought to act primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor and releasing agent.[citation needed]
  31 KB (4,379 words) - 12:23, 6 May 2024
• MDAI (category All articles with unsourced statements)
  as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. MDAI was developed
  17 KB (2,560 words) - 07:40, 12 October 2023
• Agonist
  Responsible use Scientific information Antagonist Reuptake inhibitor Releasing agent Agonist (Wikipedia) Definition of AGONIST 
  5 KB (703 words) - 23:08, 21 April 2024
• 5-Hydroxytryptophan (category All articles with unsourced statements)
  5-HTP is also popularly consumed by users of MDMA and other serotonin-releasing agents to try to reduce the negative after effects that begin during the substance's
  14 KB (1,639 words) - 17:37, 7 April 2024
• Cyclazodone (category All articles with unsourced statements)
  function. There is no evidence that releasing agents are directly neurotoxic in humans. However, large doses of releasing agents may cause indirect neurotoxicity
  19 KB (2,675 words) - 16:54, 31 March 2024
• Stimulants (category All articles with unsourced statements)
  signalling act as reuptake inhibitors (NDRIs, e.g. methylphenidate), releasing agents (NDRAs, e.g. amphetamine) or receptor ligands (e.g yohimbine). Stimulants
  11 KB (1,055 words) - 02:52, 12 May 2024
• Bufotenin (category All articles with unsourced statements)
  dangerously toxic when combined with MAOIs, RIMAs, SSRIs, stimulants or any substance which acts as a releasing agent or reuptake inhibitor of monoamine
  16 KB (2,273 words) - 19:54, 7 April 2024
• MDEA (category All articles with unsourced statements)
  entactogens like MDMA, MDA and MDAI. MDEA acts as a releasing agent and reuptake inhibitor of the monoamine neurotransmitters serotonin, dopamine and noradrenaline
  25 KB (3,654 words) - 23:46, 21 April 2024
• Reuptake inhibitor
  neurotransmitters. Responsible use Scientific information Agonist Antagonist Releasing agent Reuptake inhibitor (Wikipedia) Ravna, A. W., Sylte, I., Dahl, S. G.
  7 KB (802 words) - 23:08, 21 April 2024
• 6-APDB (category All articles with unsourced statements)
  been replaced with a methylene bridge. 6-APDB shares this furan ring with 5-APDB, 5-MAPDB and 6-MAPDB. 6-APDB acts as a releasing agent and triple reuptake
  26 KB (4,015 words) - 23:44, 21 April 2024
• Substituted amphetamines (category All articles with unsourced statements)
  amphetamine with different substitutions at various positions. An amphetamine molecule has the structure of a phenethylamine molecule with an additional
  8 KB (225 words) - 23:09, 21 April 2024
• NEP (category All articles with unsourced statements)
  may also be due to its activity as a serotonin reuptake inhibitor or releasing agent in moderate to high doses, although new research has shown very low
  18 KB (2,677 words) - 06:56, 28 April 2024
• Serotonin-norepinephrine reuptake inhibitor
  ne releasing agent (SNRA), for instance, the withdrawn appetite suppressant fenfluramine/phentermine (Fen-Phen). SNRAs primarily induce the release of
  8 KB (987 words) - 17:09, 1 August 2022
• Research chemicals
  are taken or when it is taken with drugs such as MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters
  19 KB (2,209 words) - 23:08, 21 April 2024
• Antagonist
  Responsible use Scientific information Agonist Reuptake inhibitor Releasing agent Receptor antagonist (Wikipedia) Stephenson, R. P. (February 1997). "A
  10 KB (1,282 words) - 23:08, 21 April 2024
• 5-MAPB (category All articles with unsourced statements)
  speculated that 5-MAPB acts as a releasing agent for the previously mentioned neurotransmitters. As a result, releasing agents such as 5-MAPB may exert their
  13 KB (2,233 words) - 00:32, 31 December 2022

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)